Proteomics

Dataset Information

0

Proteomic Analysis of a PLK1-Dependent, Cell Cycle Degradation Program


ABSTRACT: Targeted protein degradation by the ubiquitin-proteasome system is an essential mechanism regulating cellular division. The kinase PLK1 coordinates protein degradation at the G2/M phase of the cell cycle by promoting the binding of substrates to the E3 ubiquitin ligase SCFβTrCP. However, the magnitude to which PLK1 shapes the mitotic proteome has not been characterized. Combining deep, quantitative proteomics with pharmacologic PLK1 inhibition (PLK1i), we identified more than 200 proteins whose abundances were increased by PLK1i at G2/M. We validate many new PLK1-regulated proteins, including several substrates of the cell cycle E3 SCFCyclin F, demonstrating that PLK1 promotes proteolysis through at least two distinct SCF-family E3 ligases. Further, we found that the protein kinase A anchoring protein AKAP2 is cell cycle regulated and that its mitotic degradation is dependent on the PLK1/βTrCP-signaling axis. Interactome analysis revealed that the strongest interactors of AKAP2 function in signaling networks regulating proliferation, including MAPK, AKT, and Hippo. Altogether, our data demonstrate that PLK1 coordinates a widespread program of protein breakdown at G2/M. We propose that dynamic proteolytic changes mediated by PLK1 integrate proliferative signals with the core cell cycle machinery during cell division. This has potential implications in malignancies where PLK1 is aberrantly regulated.

INSTRUMENT(S): Orbitrap Exploris 480, Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Christine Mills  

LAB HEAD: Michael Emanuele

PROVIDER: PXD046039 | Pride | 2025-05-06

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications


Ubiquitination is an essential regulator of cell division. The kinase Polo-like kinase 1 (PLK1) promotes protein degradation at G2/M phase through the E3 ubiquitin ligase Skp1-Cul1-F box (SCF)<sup>βTrCP</sup>. However, the magnitude to which PLK1 shapes the mitotic proteome is uncharacterized. Combining quantitative proteomics with pharmacologic PLK1 inhibition revealed a widespread, PLK1-dependent program of protein breakdown at G2/M. We validated many PLK1-regulated proteins, including substra  ...[more]

Similar Datasets

2024-07-18 | PXD046783 | Pride
2024-11-01 | PXD053933 | Pride
2019-11-18 | PXD015513 | Pride
2025-05-16 | PXD061463 | Pride
2025-02-15 | PXD053197 | Pride
2024-09-09 | PXD053141 | Pride
2022-03-08 | PXD031110 | Pride
2024-09-02 | BIOMD0000000641 | BioModels
2024-02-26 | PXD036430 | Pride
2025-07-09 | PXD051886 | Pride